2018.....what's hot, not and new, page-26

DXB should come good as trials approach next year, maybe some time in the oven needed. Even still, surprised how hated it is.

FTT playing out as suggested a while back and still think PTX would have to be high on the list of BESB with AML readout later in the year.

Mark down IIL, ANP and 1AD for next year or in the case of first two, late this year.

PXS a well run, fairly high quality name and wirth watching for any placement overhang, once we find out what the raise was for.

$0.02.